NRC Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
35.4M
+1.7%
34.8M
-1.1%
35.2M
+1.7%
34.6M
+1.7%
34.0M
Cost of Revenue
13.6M
-0.6%
13.6M
-2.1%
13.9M
+12.3%
12.4M
-4.4%
13.0M
Gross Profit
21.8M
+3.2%
21.2M
-0.5%
21.3M
-4.3%
22.2M
+5.4%
21.1M
Operating Expenses
25.1M
+60.8%
15.6M
-6.0%
16.6M
+14.7%
14.5M
-25.7%
19.5M
R&D
0
0
0
0
0
SG&A
22.9M
+71.0%
13.4M
-7.1%
14.4M
+17.7%
12.3M
-30.8%
17.7M
Operating Income
-3238000
-158.1%
5.6M
+19.3%
4.7M
-39.7%
7.7M
+387.3%
1.6M
EBITDA
-1117000
-114.4%
7.7M
+13.6%
6.8M
-31.4%
9.9M
+198.3%
3.3M
Net Income
-3283000
-201.9%
3.2M
+79.2%
1.8M
-56.4%
4.1M
+3988.7%
-106000
EPS (Basic)
$-0.15
-207.1%
$0.14
+100.0%
$0.07
-61.1%
$0.18
+1900.0%
$-0.01
EPS (Diluted)
$-0.15
-207.1%
$0.14
+100.0%
$0.07
-61.1%
$0.18
+1900.0%
$-0.01
Shares (Diluted)
22.0M
+0.4%
21.9M
+0.4%
21.8M
-1.4%
22.1M
-2.3%
22.7M
NRC Health (NRC) โ€” Financials